Elvia Cowan sold $557K of Vaxcyte (PCVX)

Executed Dec 23 2025, disclosed Dec 29 2025, 6 days later, against a two-business-day limit.

Value, as filed

$557K

11,623 sh across 2 lots

Executed

Dec 23 2025

the trade date, as filed

Disclosed

Dec 29 2025

6 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Elvia Cowan SVP, Finance & CAO profile →

Elvia Cowan (SVP, Finance & CAO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales, 1 filed past the two-business-day deadline), most often in Vaxcyte, Inc. (PCVX). The largest single filing was $557K of PCVX (11,623 sh across 2 lots, as filed), executed Dec 23 2025.

The name

PCVX

Vaxcyte, Inc. PCVX · Healthcare · 41 filings in 24 months ticker →

Healthcare · Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial inf…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Elvia Cowan in PCVX

PCVXSALE Vaxcyte, Inc. $180K
3,000 sh × $60.00
Exec Apr 7
Filed Apr 8 · 5:30 PM ET PCVXSALE Vaxcyte, Inc. $146K
2,500 sh × $58.59
Exec Mar 11
Filed Mar 11 · 5:30 PM ET